DIGI POWER X ADVANCES TO CBOE CANADA
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 27 2026
0mins
Should l Buy DGX?
Source: moomoo
- Graduation Announcement: DIGI POWER X graduates are set to become part of the Canadian workforce, marking a significant milestone in their educational journey.
- Program Impact: The program aims to equip graduates with essential skills and knowledge to thrive in the energy sector, contributing to Canada's growing demand for skilled professionals.
- Future Opportunities: Graduates are expected to explore various career paths within the energy industry, enhancing their prospects in a competitive job market.
- Community Engagement: The graduation event highlights the importance of community support and collaboration in fostering educational initiatives and workforce development.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DGX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DGX
Wall Street analysts forecast DGX stock price to rise
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 195.020
Low
190.00
Averages
203.33
High
210.00
Current: 195.020
Low
190.00
Averages
203.33
High
210.00
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Quest Diagnostics Set to Announce Q1 Earnings with Strong Estimates
- Earnings Announcement Date: Quest Diagnostics is set to release its Q1 earnings on April 21 before market open, with consensus EPS estimated at $2.37, reflecting a 7.2% year-over-year increase, which indicates sustained profitability and could boost investor confidence.
- Revenue Growth Expectations: The anticipated Q1 revenue of $2.83 billion represents a 6.8% year-over-year growth, highlighting strong demand in the medical testing sector and potentially laying the groundwork for future business expansion.
- Historical Performance: Over the past two years, Quest Diagnostics has beaten both EPS and revenue estimates 100% of the time, showcasing its financial robustness and market adaptability, which enhances investor confidence in its future performance.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 5 upward revisions and 6 downward adjustments, while revenue estimates experienced 9 upward revisions with no downward changes, indicating analysts' optimistic outlook on the company's future performance, likely attracting more investor interest.
See More
DIGI POWER X INC ENTERS INTO $19.6 MILLION 24-MONTH CONTRACT WITH SUBQ AI, STARTING MAY 15, 2026 - SEC FILING
Contract Details: DIGI Power X Inc. has secured a 24-month contract with SubQ, valued at approximately $19.6 million.
Effective Date: The contract is set to take effect on May 15, 2026.
See More
DIGI POWER X INC - DISCLOSES GPU RENTAL CONTRACT WITH SUBQ AI - SEC FILING
- Announcement of Agreement: DIGI POWER X INC has announced a parental agreement with SUBQ AI regarding SEC filing.
- Focus on SEC Compliance: The agreement emphasizes compliance with SEC regulations, indicating a strategic move for transparency and governance.
See More
Wall Street Earnings Season Faces Major Test
- Earnings Season Significance: Wall Street is set for a packed earnings season featuring key companies like Capital One and Boeing, with investors eager to glean insights into the economic impact of the Iran war from these reports.
- Capital One Performance Focus: Capital One is scheduled to report earnings on Tuesday, with market attention on its consumer health metrics and the progress of its acquisitions of Discover and Brex, particularly amid rising economic uncertainties.
- Boeing Earnings Outlook: Boeing is expected to release its earnings report on Wednesday, with market focus on order volumes in both its commercial and defense sectors, as well as free cash flow performance, especially after previous unexpected losses.
- GE Vernova Order Growth: GE Vernova will report alongside Boeing, with first-quarter new orders anticipated to reach $14.4 billion, reflecting a 65% year-over-year increase, indicating strong market performance amid rising electricity demand.
See More
Wall Street Optimism Rises Amid Ceasefire Hopes
- Market Rebound: The S&P 500 and Nasdaq Composite reached all-time highs this week, with the S&P 500 surpassing 7,100 for the first time, reflecting strong investor confidence in economic recovery and suggesting further upward momentum for equities.
- Earnings Expectations: According to FactSet, the S&P 500 is projected to have a blended growth rate of 12.5% in Q1, with 78% of reporting companies exceeding expectations, providing a positive backdrop for the upcoming earnings season that could further bolster market confidence.
- Oil Price Volatility: While oil prices have fallen to around $80 per barrel, significantly below the $110 peak during the conflict, the market must remain vigilant regarding the potential impacts of U.S.-Iran tensions on global supply chains, particularly concerning the safety of transit through the Strait of Hormuz.
- Technical Fragility: Despite the market's strong short-term performance, analyst Craig Johnson warns that the rapid transition from oversold to overbought conditions masks underlying macroeconomic risks, urging investors to remain cautious and focus on high-quality investment opportunities.
See More
Quest Diagnostics Q4 Earnings Exceed Expectations
- Strong Earnings Report: Quest Diagnostics reported Q4 revenues of $2.81 billion, reflecting a 7.1% year-over-year increase, exceeding analysts' expectations by 1.9%, indicating robust performance amid stable demand that is likely to bolster market confidence.
- Industry Performance: The testing and diagnostics services sector collectively surpassed analysts' consensus estimates by 2.1%, supported by stable revenue streams and the demand from an aging population, despite facing pricing pressures and regulatory compliance challenges.
- Market Reaction: Despite Quest's strong earnings, the stock price has remained flat since the report, currently trading at $192.85, reflecting market uncertainty regarding future growth, which may impact investor confidence.
- Future Outlook: With the expansion of personalized medicine and the adoption of rapid testing, the industry's outlook is optimistic; however, vigilance is needed regarding reimbursement uncertainties and increasing competition, making continuous investment in new technologies crucial for sustaining growth.
See More
Quest Diagnostics Set to Announce Q1 Earnings with Strong Estimates
- Earnings Announcement Date: Quest Diagnostics is set to release its Q1 earnings on April 21 before market open, with consensus EPS estimated at $2.37, reflecting a 7.2% year-over-year increase, which indicates sustained profitability and could boost investor confidence.
- Revenue Growth Expectations: The anticipated Q1 revenue of $2.83 billion represents a 6.8% year-over-year growth, highlighting strong demand in the medical testing sector and potentially laying the groundwork for future business expansion.
- Historical Performance: Over the past two years, Quest Diagnostics has beaten both EPS and revenue estimates 100% of the time, showcasing its financial robustness and market adaptability, which enhances investor confidence in its future performance.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 5 upward revisions and 6 downward adjustments, while revenue estimates experienced 9 upward revisions with no downward changes, indicating analysts' optimistic outlook on the company's future performance, likely attracting more investor interest.
See More
DIGI POWER X INC ENTERS INTO $19.6 MILLION 24-MONTH CONTRACT WITH SUBQ AI, STARTING MAY 15, 2026 - SEC FILING
Contract Details: DIGI Power X Inc. has secured a 24-month contract with SubQ, valued at approximately $19.6 million.
Effective Date: The contract is set to take effect on May 15, 2026.
See More
DIGI POWER X INC - DISCLOSES GPU RENTAL CONTRACT WITH SUBQ AI - SEC FILING
- Announcement of Agreement: DIGI POWER X INC has announced a parental agreement with SUBQ AI regarding SEC filing.
- Focus on SEC Compliance: The agreement emphasizes compliance with SEC regulations, indicating a strategic move for transparency and governance.
See More
Wall Street Earnings Season Faces Major Test
- Earnings Season Significance: Wall Street is set for a packed earnings season featuring key companies like Capital One and Boeing, with investors eager to glean insights into the economic impact of the Iran war from these reports.
- Capital One Performance Focus: Capital One is scheduled to report earnings on Tuesday, with market attention on its consumer health metrics and the progress of its acquisitions of Discover and Brex, particularly amid rising economic uncertainties.
- Boeing Earnings Outlook: Boeing is expected to release its earnings report on Wednesday, with market focus on order volumes in both its commercial and defense sectors, as well as free cash flow performance, especially after previous unexpected losses.
- GE Vernova Order Growth: GE Vernova will report alongside Boeing, with first-quarter new orders anticipated to reach $14.4 billion, reflecting a 65% year-over-year increase, indicating strong market performance amid rising electricity demand.
See More
Wall Street Optimism Rises Amid Ceasefire Hopes
- Market Rebound: The S&P 500 and Nasdaq Composite reached all-time highs this week, with the S&P 500 surpassing 7,100 for the first time, reflecting strong investor confidence in economic recovery and suggesting further upward momentum for equities.
- Earnings Expectations: According to FactSet, the S&P 500 is projected to have a blended growth rate of 12.5% in Q1, with 78% of reporting companies exceeding expectations, providing a positive backdrop for the upcoming earnings season that could further bolster market confidence.
- Oil Price Volatility: While oil prices have fallen to around $80 per barrel, significantly below the $110 peak during the conflict, the market must remain vigilant regarding the potential impacts of U.S.-Iran tensions on global supply chains, particularly concerning the safety of transit through the Strait of Hormuz.
- Technical Fragility: Despite the market's strong short-term performance, analyst Craig Johnson warns that the rapid transition from oversold to overbought conditions masks underlying macroeconomic risks, urging investors to remain cautious and focus on high-quality investment opportunities.
See More
Quest Diagnostics Q4 Earnings Exceed Expectations
- Strong Earnings Report: Quest Diagnostics reported Q4 revenues of $2.81 billion, reflecting a 7.1% year-over-year increase, exceeding analysts' expectations by 1.9%, indicating robust performance amid stable demand that is likely to bolster market confidence.
- Industry Performance: The testing and diagnostics services sector collectively surpassed analysts' consensus estimates by 2.1%, supported by stable revenue streams and the demand from an aging population, despite facing pricing pressures and regulatory compliance challenges.
- Market Reaction: Despite Quest's strong earnings, the stock price has remained flat since the report, currently trading at $192.85, reflecting market uncertainty regarding future growth, which may impact investor confidence.
- Future Outlook: With the expansion of personalized medicine and the adoption of rapid testing, the industry's outlook is optimistic; however, vigilance is needed regarding reimbursement uncertainties and increasing competition, making continuous investment in new technologies crucial for sustaining growth.
See More
